You searched for "regeneration"
American Glaucoma Society (AGS) Annual Meeting 2025
26 February 2025
-2 March 2025
Important Dates September 5, 2024: Abstract Submission and Surgical Video Submission Opens October 10, 2024 : Abstract Submission Site ClosesOctober 17, 2024: Registration and Housing open to AGS Members OnlyOctober 17, 2024: Surgical Video Submission ClosesNovember 15, 2024: Registration and...
Registration live for 100% Ophthalmology 2025
19 September 2024
|
ophthalmology, events, conferences, industry, 100%, 100% Optical, 100% ophthalmology, London, meetings
Organisers of 100% Optical have announced that visitor registrations for 100% Ophthalmology 2025 are now live for the show set to take place at London’s ExCeL from 1–3 March. Featuring as a co-located event with 100% Optical, 100% Ophthalmology, a...
A missed intraocular telescope – an opportunity to re-focus the evidence
4 February 2021
| Hani Hasan, Jennifer McMahon, Guy Smith
|
EYE - Cornea, EYE - Vitreo-Retinal, EYE - Imaging, EYE - General
Intraocular telescopes allow magnification of the image so that it would be projected into a larger area of the macula, this makes the central defect caused by dry age-related macular degeneration (AMD) smaller. The most common approach is a Galilean...
Moorfields Eye Hospital, UCL Institute of Ophthalmology and Topcon Healthcare, Inc. launch Cascader Limited to advance AI-driven eyecare and Oculomics
9 May 2025
|
AI, Artificial intelligence, oculomics, news, Moorfields, Cascader, imaging, industry news
Moorfields Eye Hospital NHS Foundation Trust, the UCL Institute of Ophthalmology (IoO), and Topcon Healthcare today announced the launch of Cascader Limited, a new medical technology company that aims to transform the detection and management of eye disease through artificial...
Combined Vismodegib and Mohs surgery
1 April 2019
| James Hsuan
|
EYE - Oculoplastic
This is a report of eight patients with locally advanced periocular basal cell carcinoma who were treated with Vismodegib prior to Mohs micrographic surgery. The rationale for the combined treatment plan was that long-term Vismodegib is poorly tolerated due to...
COVID-related mucormycosis
The authors report a retrospective case-control study of 73 patients with COVID-19 associated mucormycosis (CAM) between 1st March and 30th May 2021. They compared various factors between the two groups – patients who survived CAM (47 [64%]) and those that...Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity
5 June 2023
| Rod McNeil
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...
LambdaVision aims to refine process for in-space manufacturing of artificial retinas through ISS National Lab-sponsored investigation
1 February 2024
|
ISS, retinal, artificial, LambdaVision, industry, innovation, retinitis pigmentosa, RP
Approximately 1.5 million people worldwide are affected by retinitis pigmentosa, a rare genetic disorder that causes vision loss. Currently there is no cure, but researchers from LambdaVision are turning to the International Space Station (ISS) National Laboratory to look for...
Advances and developments in medical retina
The author provides an update on late breaking clinical trial results in neovascular age-related macular degeneration (nAMD) and presentations on diabetes management from the American Academy of Ophthalmology Retina Subspecialty Day, held during the Academy’s annual meeting in Chicago, October...Four key questions and answers for glaucoma practitioners
1 October 2018
| Chrysostomos D Dimitriou
|
EYE - Glaucoma
In this discussion paper the authors pose four questions for the clinician diagnosing and monitoring glaucoma, and supply evidence-based answers. Worldwide, the most common functional test used to diagnose and monitor glaucoma is static automated perimetry, most typically with a...
Haag-Streit to host Biometry Focus Month 2024
Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is pleased to announce that Haag-Streit will be bringing together experts for Biometry Focus Month 2024, featuring a series...Charles Bonnet Syndrome emerges from the shadows
10 November 2020
There has been a ground-breaking response to the online Charles Bonnet Syndrome Patient Information event on
16 November.